{
  "round": 3,
  "request": {
    "reason": "现有候选在机制支持上不足，path_disjointness 仅为 1，需引入新靶点或独立作用机制的候选",
    "n": 4
  },
  "prev_hypotheses": [
    "Eculizumab",
    "Ravulizumab",
    "Aflibercept",
    "Corticosteroids",
    "Plasmapheresis",
    "Methotrexate",
    "Cyclophosphamide",
    "Tacrolimus",
    "Copanlisib",
    "Rituximab",
    "Belimumab",
    "Sunitinib"
  ],
  "status": "regenerated",
  "generated_seeds": [
    "Eculizumab",
    "Ravulizumab",
    "Avacopan",
    "Complement C5 Inhibitors",
    "Cangrelor",
    "Nivolumab",
    "Eculizumab Biosimilar",
    "Tafamidis",
    "Ertugliflozin",
    "Daratumumab",
    "Obinutuzumab",
    "Caplacizumab"
  ],
  "new_hypotheses": [
    "Eculizumab",
    "Ravulizumab",
    "Avacopan",
    "Complement C5 Inhibitors",
    "Cangrelor",
    "Nivolumab",
    "Eculizumab Biosimilar",
    "Tafamidis",
    "Ertugliflozin",
    "Daratumumab",
    "Obinutuzumab",
    "Caplacizumab"
  ]
}